The Enforcement Directorate (ED) on Monday carried out searches at seven locations in Chennai linked to Sreesan Pharma under money laundering in the case of 'Coldrif' cough syrup, which caused the death of several children, officials said.
BJP leader K. Annamalai has criticised the Tamil Nadu government for its handling of a case involving a private pharmaceutical company in Kanchipuram, allegedly linked to the deaths of 23 people in Madhya Pradesh and three children in Rajasthan due to a faulty drug.
Senior Congress leader Kamal Nath expressed grief over the 22 deaths caused by the consumption of Coldrif cough syrup and held the state government responsible for the tragedy.
Samsung Biologics Co is accelerating its expansion in Japan, the world's third-largest pharmaceutical market. The South Korean company has signed contracts with half of Japan's top 10 pharmaceutical and biotech companies, rapidly strengthening its presence in the region, according to a repor
The discussion, organised for the delegation to initiate an interaction with the Indian American community residing in New York, was attended by MPs Captain Brijesh Chowta, Nishikant Dubey, Ujjwal Deorao Nikam, S Phangnon Konyak, Dr Medha Vishram Kulkarni, Poonam Ben Maadam, Vamsi Krishna Ga
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
The Health Secretary's statement came after Madhya Pradesh Police arrested the owner of Sresan Pharmaceuticals from Tamil Nadu, in connection with the deaths of 20 children in the state, allegedly caused by the consumption of Coldrif cough syrup manufactured by the company.
Bengaluru (Karnataka) [India], October 10: Newtral Technologies, an AI-powered sustainability platform, has secured $600,000 in seed funding from NOW Venture Studio's Accelerate program focused on deeptech and climate-tech startups. The partnership will fuel Newtral's mission to build AI-nat
Ahmedabad (Gujarat) [India], October 10: Rushil Decor Limited (NSE: RUSHIL, BSE: 533470), a leader in the Indian decorative laminate and MDF panel board industry, is pleased to announce the commencement of trial run production under Phase 2 of its advanced Jumbo Size Laminates manufacturing
New Delhi [India], October 10: The Pharmaceutical industry is experiencing high growth in India, due to high demand for pharma medicines, increased population, and rising health awareness.
Mumbai (Maharashtra) [India], October 10: Fredun Pharmaceuticals Limited (BSE - FREDUN | 539730) is one of the leading pharmaceuticals formulation manufacturing companies in India. The Company, diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products